
|Articles|August 15, 2022
The Mainstream Patient: August 15
Author(s)Kaitlyn Bader, Associate Editor
This week's edition of the Mainstream Patient features stories about adult acne, Native American beauty products, a non-irritating retinol serum, beauty brands that support abortion rights, and more.
Advertisement
In this week’s edition, Self interviews Keke Palmer about adult acne and Vogue talks Tower 28's hypochlorous acid spray. Cosmopolitan lists 13 Native American and Indigenous-owned beauty products and Glamour discusses undereye patches for brighter eyes. Elle examines StriVectin's Advanced Retinol Nightly Multi-Correct Serum and Allure dives into beauty brands that support abortion rights.
Keke Palmer Would Love for Someone to Cure Adult Acne Already
TikTok Made Me Buy It: This Facial Spray Beloved for Its Eczema and Acne-Soothing Powers
13 Native American and Indigenous-Owned Beauty Products to Try
The 30 Best Undereye Patches to Make Mornings a Little Less Rough
Finally, A Retinol Serum That Gives Me Visible Results Without Irritation
Does Your Favorite Beauty Brand Support Abortion Rights?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5















